MiR-486 was previously reported to inhibit PAI-1 expression in liposarcoma in vitro to inhibit cancer cell growth and repressing miR-486 elevated PAI-1 cellular level, helping to maintain liposarcoma cell survival [114]. This evidence concerns the gene SERPINE1 and cancer.